Breast Cancer
Soy isoflavone daidzein improved capacity of tamoxifen to prevent mammary tumors
Published in Cancer Weekly, May 24th, 2005
According to recent research published in the European Journal of Cancer, "The aim of this study was to determine how the efficacy of tamoxifen is affected when combined with soy isoflavones. To address this, female Sprague-Dawley rats were placed on diets supplemented with tamoxifen, genistein, daidzein, or a combination of each isoflavone with tamoxifen; a week later mammary tumors were induced by 7,12 dimethylbenzanthracene. The most effective diet was the tamoxifen/daidzein combination."
"It reduced tumor multiplicity by 76%, tumor incidence by 35%, tumor burden by over 95%, and increased tumor latency by 62% compared with positive controls. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-05-24)
More Articles from Cancer Weekly
- Cancer Drugs
Epoetin alfa increased hemoglobin levels and improved quality of life - Prostate Cancer
Ultraviolet radiation lowered risk of prostate cancer and other internal cancers - Skin Cancer
Natural antioxidant from olive oil prevented protein damage from UV radiation - Acute Myelocytic Leukemia
Report published on study using Genasense Injection for AML - Adenosquamous Cancer
Case report of adenosquamous carcinoma of the prostate presented - Adriamycin
p53 may have a role in adriamycin-induced caspase-independent apoptosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
